WASHINGTON -- Even after weeks of intense and emotionally charged coverage by the news media, a poll study released today shows that mad cow disease does not even rank among the top two food-related health concerns.
The survey, commissioned by the Food Marketing Institute (FMI), examined the public's attitude toward a list of food-related health concerns, and found that "food poisoning" and "foodborne bacteria" -- issues dealing with food storage and preparation -- remain the greatest concerns. "Mad cow disease" ranked just higher than "irradiated meat" and "cloned foods."
Tim Hammonds, president and CEO of FMI, which represents the retail and wholesale food industry, says the poll results "substantiate that Americans inherently trust the safety of the U.S. food supply and realize the risk of contracting mad cow disease is extremely remote. It also supports what large grocery store chains are seeing -- consumers are still eating beef."
In addition, 22 percent of respondents cited the media coverage as being "negatively biased." There is also evidence that this bias may have inadvertently contributed to confusion over how mad cow disease is contracted. When asked what part of the cow becomes infected, less than 29 percent of adults correctly identified the brain, spine or nervous system. Conversely, the majority of Americans (54 percent) either did not know what part becomes infected or provided an incorrect response (such as all cow meat).
Wilson Research Strategies, an opinion research firm headquartered in McLean, Va., conducted two nationwide surveys of 766 adults Dec. 4-8, 2003 and Jan. 5-8, 2004. Both studies have margin or errors of +/-3.6 percent at the 95 percent confidence interval.
Source: Wilson Research Strategies
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.